Skip to content
Search

Latest Stories

More than half of pharmacists looking to change roles, PDA survey reveals

More than half of pharmacists working in England are considering changing their roles over the next 12-18 months because of work-related issues, a recent survey by The Pharmacists' Defence Association (PDA) revealed.

The survey which concluded on February 18, 2022 had more than 2,500 participants including employed and locum pharmacists from all four UK nations.


In the survey, PDA asked respondents about their current roles and future career plans.

The initial feedback showed that unsatisfactory pay and working environments, lack of professional fulfilment, and poor management were the key factors for pharmacy professionals to reconsider their current positions.

Response from those working in pharmacies owned by the Company Chemists’ Association (CCA) members showed that 54 per cent of them are looking for a change in the next 12 to 18 months, 17 per cent want to become locums and 23 per cent wish to work in another sector. Around 11 per cent of the lot are planning to retire, while a shocking 27 per cent intend to leave pharmacy altogether.

Around 56 per cent of the total respondents said they have stopped working part-time and of these 74 per cent would not consider a full-time position in future.

A majority of the respondents also stated they do not believe that there is a shortage of pharmacists.

Mark K Mark Koziol, chairman, PDA

PDA chairman, Mark Koziol said: “Many pharmacists who work for CCA members have made clear that job dissatisfaction, substandard pay and in particular work environments have a strong bearing on their propensity to stay in their current post.

"What many pharmacists seek is professional fulfilment, safer working environments, career development, and more sociable working hours.

"63% of respondents to our survey said that they do not believe that there is a shortage of pharmacists in the UK, a view that is supported by data from various government bodies. The survey results appear to debunk the idea that a shortage of pharmacists is causing an increase in the CCA members’ vacancy rates.”

He added that the combined outcome of this survey and that of the 2021 Safer Pharmacies Survey, “paint a disappointing and alarming picture for pharmacists.”

“The PDA believes this should be particularly concerning for CCA members. Something urgently needs to be done about improving the working conditions of pharmacists, to protect their health and wellbeing and improve recruitment and retention.”

The fact that many pharmacists are considering leaving the profession indicates an enormous human and societal investment is being squandered, he added.

Further, the PDA urged CCA representatives to place the responsibility for these problems on employers.

Koziol added that employers should “face up to their responsibility for the working environments experienced by their pharmacists and put in place the repairs that are long overdue.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less